about
Notch pathway activation is essential for maintenance of stem-like cells in early tongue cancerDrug-sensitive FGFR3 mutations in lung adenocarcinoma.HER2 Reactivation through Acquisition of the HER2 L755S Mutation as a Mechanism of Acquired Resistance to HER2-targeted Therapy in HER2+ Breast Cancer.GPCRs profiling and identification of GPR110 as a potential new target in HER2+ breast cancerTowards personalized treatment for early stage HER2-positive breast cancerTargeting the Mevalonate Pathway to Overcome Acquired Anti-HER2 Treatment Resistance in Breast Cancer
P50
description
researcher
@en
wetenschapper
@nl
name
Vidyalakshmi Sethunath
@en
Vidyalakshmi Sethunath
@nl
type
label
Vidyalakshmi Sethunath
@en
Vidyalakshmi Sethunath
@nl
prefLabel
Vidyalakshmi Sethunath
@en
Vidyalakshmi Sethunath
@nl
P31
P496
0000-0002-3308-3063